FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133193068> ?p ?o ?g. }

• W2133193068 endingPage "396" @default.
• W2133193068 startingPage "389" @default.
• W2133193068 abstract "Administration of anti-CD19 chimeric antigen receptor (CAR)-modified T cells for B-cell malignancies has been remarkably effective in recent clinical trials. To investigate the critical parameters affecting efficacy and evaluated the safety of using CAR T cells targeting CD19 in B-lineage malignancies. We performed a systematic review of reported phase I clinical trials using CAR T cells targeting CD19 in B-lineage malignancies.We searched Medline and Embase for studies on anti-CD19 CAR-modified T cells in patients with B-cell malignancies in October 2014. Univariate analyses were performed using the Kaplan-Meier method, and a Cox regression model was used to determine the independent prognostic factors of progression-free survival (PFS).Six trials involving 50 patients were included in this review. After CAR T-cell infusion, the overall response rate was 48% (complete responses in 24%). The 6-month PFS and 1-year PFS were 43% and 27%, respectively. Statistically significant factors favorably influencing PFS were conditioning chemotherapy (P < 0.001), B-cell aplasia (P = 0.040), and durable persistence of CAR T cells (P = 0.013) in univariate analyses. After multivariate analysis, conditioning chemotherapy remained as an independent prognostic factor for PFS. The most common adverse events were fever, hypotension, rigor, fatigue, bacteremia, chill, dyspnea, and headache, but all were temporary and resolved.Anti-CD19 CAR-modified T cells have shown therapeutic efficacy in patients with B-lineage malignancies and were well tolerated in most patients. Conditioning chemotherapy is a prerequisite to improve the clinical outcome." @default.
• W2133193068 created "2016-06-24" @default.
• W2133193068 creator A5021685221 @default.
• W2133193068 creator A5027187705 @default.
• W2133193068 creator A5031646590 @default.
• W2133193068 creator A5034681074 @default.
• W2133193068 creator A5046779498 @default.
• W2133193068 creator A5052971827 @default.
• W2133193068 creator A5079341905 @default.
• W2133193068 creator A5090777984 @default.
• W2133193068 date "2015-07-03" @default.
• W2133193068 modified "2023-10-14" @default.
• W2133193068 title "Anti-CD19 chimeric antigen receptor-modified T cells for B-cell malignancies: a systematic review of efficacy and safety in clinical trials" @default.
• W2133193068 cites W1607012924 @default.
• W2133193068 cites W1963522404 @default.
• W2133193068 cites W1964337055 @default.
• W2133193068 cites W1966542058 @default.
• W2133193068 cites W1967517831 @default.
• W2133193068 cites W1971746066 @default.
• W2133193068 cites W1972297696 @default.
• W2133193068 cites W1983412131 @default.
• W2133193068 cites W1989273697 @default.
• W2133193068 cites W2010607826 @default.
• W2133193068 cites W2045475405 @default.
• W2133193068 cites W2047192675 @default.
• W2133193068 cites W2047420649 @default.
• W2133193068 cites W2051549641 @default.
• W2133193068 cites W2056266520 @default.
• W2133193068 cites W2057389857 @default.
• W2133193068 cites W2068302119 @default.
• W2133193068 cites W2068890283 @default.
• W2133193068 cites W2076991609 @default.
• W2133193068 cites W2082665569 @default.
• W2133193068 cites W2082708772 @default.
• W2133193068 cites W2087857484 @default.
• W2133193068 cites W2105400883 @default.
• W2133193068 cites W2118796952 @default.
• W2133193068 cites W2124513722 @default.
• W2133193068 cites W2127033802 @default.
• W2133193068 cites W2130011407 @default.
• W2133193068 cites W2130338247 @default.
• W2133193068 cites W2141410122 @default.
• W2133193068 cites W2146059841 @default.
• W2133193068 cites W2165580475 @default.
• W2133193068 cites W2167550136 @default.
• W2133193068 cites W2170513194 @default.
• W2133193068 doi "https://doi.org/10.1111/ejh.12602" @default.
• W2133193068 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26115358" @default.
• W2133193068 hasPublicationYear "2015" @default.
• W2133193068 type Work @default.
• W2133193068 sameAs 2133193068 @default.
• W2133193068 citedByCount "43" @default.
• W2133193068 countsByYear W21331930682015 @default.
• W2133193068 countsByYear W21331930682016 @default.
• W2133193068 countsByYear W21331930682017 @default.
• W2133193068 countsByYear W21331930682018 @default.
• W2133193068 countsByYear W21331930682019 @default.
• W2133193068 countsByYear W21331930682020 @default.
• W2133193068 countsByYear W21331930682021 @default.
• W2133193068 countsByYear W21331930682022 @default.
• W2133193068 countsByYear W21331930682023 @default.
• W2133193068 crossrefType "journal-article" @default.
• W2133193068 hasAuthorship W2133193068A5021685221 @default.
• W2133193068 hasAuthorship W2133193068A5027187705 @default.
• W2133193068 hasAuthorship W2133193068A5031646590 @default.
• W2133193068 hasAuthorship W2133193068A5034681074 @default.
• W2133193068 hasAuthorship W2133193068A5046779498 @default.
• W2133193068 hasAuthorship W2133193068A5052971827 @default.
• W2133193068 hasAuthorship W2133193068A5079341905 @default.
• W2133193068 hasAuthorship W2133193068A5090777984 @default.
• W2133193068 hasConcept C121608353 @default.
• W2133193068 hasConcept C126322002 @default.
• W2133193068 hasConcept C143998085 @default.
• W2133193068 hasConcept C147483822 @default.
• W2133193068 hasConcept C197934379 @default.
• W2133193068 hasConcept C203014093 @default.
• W2133193068 hasConcept C2776694085 @default.
• W2133193068 hasConcept C2777701055 @default.
• W2133193068 hasConcept C2778957590 @default.
• W2133193068 hasConcept C3875195 @default.
• W2133193068 hasConcept C535046627 @default.
• W2133193068 hasConcept C71924100 @default.
• W2133193068 hasConceptScore W2133193068C121608353 @default.
• W2133193068 hasConceptScore W2133193068C126322002 @default.
• W2133193068 hasConceptScore W2133193068C143998085 @default.
• W2133193068 hasConceptScore W2133193068C147483822 @default.
• W2133193068 hasConceptScore W2133193068C197934379 @default.
• W2133193068 hasConceptScore W2133193068C203014093 @default.
• W2133193068 hasConceptScore W2133193068C2776694085 @default.
• W2133193068 hasConceptScore W2133193068C2777701055 @default.
• W2133193068 hasConceptScore W2133193068C2778957590 @default.
• W2133193068 hasConceptScore W2133193068C3875195 @default.
• W2133193068 hasConceptScore W2133193068C535046627 @default.
• W2133193068 hasConceptScore W2133193068C71924100 @default.
• W2133193068 hasFunder F4320307500 @default.
• W2133193068 hasIssue "4" @default.
• W2133193068 hasLocation W21331930681 @default.
• W2133193068 hasLocation W21331930682 @default.

• next